Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Rosenberg

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Annals of Neurology|August 1, 1989
Perceptual-motor and attentional correlates of developmental dyscalculiaP B Rosenberg
Journal of Clinical Psychopharmacology|February 1, 1991
NMS-Like syndrome with a lithium/doxepin combinationP B Rosenberg, C A Pearlman
The Journal of Clinical Psychiatry|June 1, 1991
Methylphenidate in depressed medically ill patientsP B Rosenberg, I Ahmed, S Hurwitz
Cell Calcium|April 5, 2017
The role of STIM1 and SOCE in smooth muscle contractilityC H Feldman, C A Grotegut, P B Rosenberg
Clinical Neuropharmacology|October 6, 2000
Nefazodone in the adjunctive therapy of schizophrenia: an open-label exploratory studyP B Rosenberg, R B Rosse, B L Schwartz, et al.
International Journal of Geriatric Psychiatry|February 16, 2006
An open-label study of escitalopram (Lexapro) for the treatment of 'Depression of Alzheimer's disease' (dAD)V Rao, J R Spiro, P B Rosenberg, et al.
Clinical Neuropharmacology|August 1, 1997
Methylene blue adjuvant therapy of schizophreniaS I Deutsch, R B Rosse, B L Schwartz, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 15, 2019
Tetrahydrocannabinol Has Potential for Treating Agitation in Alzheimer's DiseaseP B Rosenberg, J D Outen, H Amjad, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 StudyD M Rentz, P B Rosenberg, R A Sperling, et al.
The Journal of Prevention of Alzheimer'S Disease|February 11, 2021
Longitudinal Course of Agitation and Aggression in Patients with Alzheimer's Disease in a Cohort Study: Methods, Baseline and Longitudinal Results of the A3C StudyA De Mauleon, J Delrieu, C Cantet, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Annals of Neurology|August 1, 1989
Perceptual-motor and attentional correlates of developmental dyscalculiaP B Rosenberg
Journal of Clinical Psychopharmacology|February 1, 1991
NMS-Like syndrome with a lithium/doxepin combinationP B Rosenberg, C A Pearlman
The Journal of Clinical Psychiatry|June 1, 1991
Methylphenidate in depressed medically ill patientsP B Rosenberg, I Ahmed, S Hurwitz
Cell Calcium|April 5, 2017
The role of STIM1 and SOCE in smooth muscle contractilityC H Feldman, C A Grotegut, P B Rosenberg
Clinical Neuropharmacology|October 6, 2000
Nefazodone in the adjunctive therapy of schizophrenia: an open-label exploratory studyP B Rosenberg, R B Rosse, B L Schwartz, et al.
International Journal of Geriatric Psychiatry|February 16, 2006
An open-label study of escitalopram (Lexapro) for the treatment of 'Depression of Alzheimer's disease' (dAD)V Rao, J R Spiro, P B Rosenberg, et al.
Clinical Neuropharmacology|August 1, 1997
Methylene blue adjuvant therapy of schizophreniaS I Deutsch, R B Rosse, B L Schwartz, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 15, 2019
Tetrahydrocannabinol Has Potential for Treating Agitation in Alzheimer's DiseaseP B Rosenberg, J D Outen, H Amjad, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 StudyD M Rentz, P B Rosenberg, R A Sperling, et al.
The Journal of Prevention of Alzheimer'S Disease|February 11, 2021
Longitudinal Course of Agitation and Aggression in Patients with Alzheimer's Disease in a Cohort Study: Methods, Baseline and Longitudinal Results of the A3C StudyA De Mauleon, J Delrieu, C Cantet, et al.
Pageof 2